Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin an dantomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006

被引：52

作者：

Holmes, Robert L. ^{[1
]}

Jorgensen, James H. ^{[2
,3
]}

机构：

[1] Brooke Army Med Ctr, Infect Dis Serv, Ft San Houston, TX 78234 USA

[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78201 USA

[3] Univ Hosp, San Antonio, TX 78201 USA

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2008年 / 52卷 / 02期

关键词：

D O I：

10.1128/AAC.00945-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We assessed MICs and minimal bactericidal concentrations of vancomycin, daptomycin, and nine other antimicrobials against methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006. No vancomycin, daptomycin, or linezolid resistance was observed. Clindamycin, gentamicin, and ciprofloxacin resistance decreased significantly. No tolerance to vancomycin or daptomycin was observed, nor was MIC creep seen.

引用

页码：757 / 760

页数：4

共 22 条

[1]

[Anonymous], 1999, M26A NAT COMM CLIN L

[2] Reversion of the glycopeptide resistance phenotype in Staphylococcus aureus clinical isolates [J].

Boyle-Vavra, S ;

Berke, SK ;

Lee, JC ;

Daum, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (02) :272-277

[3] Staphylococcus aureus bacteremia -: Recurrence and the impact of antibiotic treatment in a prospective multicenter study [J].

Chang, FY ;

Peacock, JE ;

Musher, DM ;

Triplett, P ;

MacDonald, BB ;

Mylotte, JM ;

O'Donnell, A ;

Wagener, MM ;

Yu, VL .

MEDICINE, 2003, 82 (05) :333-339

[4]

Clinical and laboratory Standards Institute, 2007, M100S17 CLSI

[5]

Clinical and Laboratory Standards Institute, 2006, METH DIL ANT SUSC TE

[6]

ENA J, 1993, J CHEMOTHERAPY, V5, P17

[7] High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections -: Efficacy and toxicity [J].

Hidayat, Levita K. ;

Hsu, Donald I. ;

Quist, Ryan ;

Shriner, Kimberly A. ;

Wong-Beringer, Annie .

ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (19) :2138-2144

[8] Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacterernia [J].

Howden, Benjamin P. ;

Johnson, Paul D. R. ;

Ward, Peter B. ;

Stinear, Timothy P. ;

Davies, John K. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (09) :3039-3047

[9] Microbiological features of vancomycin in the 21st century: Minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains [J].

Jones, RN .

CLINICAL INFECTIOUS DISEASES, 2006, 42 :S13-S24

[10]

JORGENSEN JH, 1999, 39 INT C ANT AG CHEM, P162

← 1 2 3 →